Marked activity of bortezomib, rituximab, and dexamethasone (BORID) in heavily pretreated patients with mantle cell lymphoma.
暂无分享,去创建一个
A. Chott | H. Kaufmann | J. Drach | M. Raderer | C. Zielinski | S. Seidl | V. Sagaster | O. Pichelmayer
暂无分享,去创建一个
A. Chott | H. Kaufmann | J. Drach | M. Raderer | C. Zielinski | S. Seidl | V. Sagaster | O. Pichelmayer